Determination of teicoplanin in human plasma and urine by affinity and reversed-phase high-performance liquid chromatography. 1987

E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
Merrel Dow Research Institute, Lepetit Research Centre, Gerenzano, VA, Italy.

A sensitive, highly selective and simple high-performance liquid chromatographic method for the determination of teicoplanin, a novel glycopeptide antibiotic, composed of six components, in human plasma and urine is described. After an isolation step by affinity chromatography, the antibiotic substances were chromatographed on a Nucleosil C18 column with phosphate buffer-acetonitrile according to a gradient profile. All the components were detected by their UV absorption at 240 nm. The concentration of teicoplanin was determined by using the external standard procedure. This method was applied to the sum of the six major components as well as to each of them separately. The linearity of the method was checked between 0.5 and 50 micrograms/ml for plasma and between 2 and 50 micrograms/ml for urine. The limit of detection was 0.1 microgram/ml for both biological fluids. The coefficients of variation of the between-day assays did not exceed 8.6 and 8.9% in plasma and urine, respectively. The application of the method to a pharmacokinetic study of teicoplanin after a single intravenous therapeutic dose in a patient is reported. This rapid technique also appears to be suitable for drug monitoring.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D017334 Teicoplanin Lipoglycopeptide antibiotic from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety. Teichomycin,Targocid,Teichomycin A2

Related Publications

E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
March 2005, Journal of pharmaceutical and biomedical analysis,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
October 1995, Journal of chromatography. B, Biomedical applications,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
April 1986, Journal of chromatography,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
August 2000, Journal of chromatography. A,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
January 1982, Journal of chromatography,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
November 1980, Journal of chromatography,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
October 1992, Journal of chromatography,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
September 1988, Journal of chromatography,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
March 1987, Yao xue xue bao = Acta pharmaceutica Sinica,
E Riva, and N Ferry, and A Cometti, and G Cuisinaud, and G G Gallo, and J Sassard
January 1989, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!